Literature DB >> 34313525

Piwi-interacting RNA-651 promotes cell proliferation and migration and inhibits apoptosis in breast cancer by facilitating DNMT1-mediated PTEN promoter methylation.

Ting Liu1, Juan Wang1, Lei Sun1, Miao Li1, Xin He1, Jue Jiang1, Qi Zhou1.   

Abstract

Piwi-interacting RNAs (piRNAs/piRs) are small non-coding RNAs that play important roles in stablizing genome through silencing transposable genetic elements. The piR-651 was reported to be dysregulated in several human solid cancer tissues, such as gastric and lung cancers. However, the role of piRNA-651 in carcinogenesis of breast cancer has not been defined. We found that piR-651 was highly expressed in breast cancer tissues and cell lines. Overexpression of piR-651 facilitated cell proliferation and invasion, restrained cell apoptosis and the percentage of arrested cells in G0/G1 phase, accompanied by upregulated expression of oncogenes (MDM2, CDK4 and Cyclin D1), whereas piR-651 downregulation showed the opposite effects. Additionally, piR-651 could promote phosphatase and tensin homolog (PTEN) methylation and its downregulated expression by recruiting DNA methyltransferase 1 (DNMT1) to the PTEN promoter region through complex formation with PIWIL2. PTEN overexpression reversed the effects of upregulated piR-651 on cell functions. This study reveals that piR-651 promotes proliferation and migration and induces apoptosis of breast cancer cells by facilitating DNMT1-mediated PTEN promoter methylation, which may provide a potential therapeutic mechanism for breast cancer.

Entities:  

Keywords:  Breast cancer; DNMT1; PTEN; methylation; piR-651

Mesh:

Substances:

Year:  2021        PMID: 34313525      PMCID: PMC8409782          DOI: 10.1080/15384101.2021.1956090

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   5.173


  27 in total

1.  PIWI-interacting RNA 021285 is involved in breast tumorigenesis possibly by remodeling the cancer epigenome.

Authors:  Alan Fu; Daniel I Jacobs; Aaron E Hoffman; Tongzhang Zheng; Yong Zhu
Journal:  Carcinogenesis       Date:  2015-07-25       Impact factor: 4.944

2.  PTEN methylation involved in benzene-induced hematotoxicity.

Authors:  Jing Yang; Xin Zuo; Wenlin Bai; Piye Niu; Lin Tian; Ai Gao
Journal:  Exp Mol Pathol       Date:  2014-03-27       Impact factor: 3.362

3.  piR-31470 epigenetically suppresses the expression of glutathione S-transferase pi 1 in prostate cancer via DNA methylation.

Authors:  Ling Zhang; Xiannan Meng; Chun Pan; Feng Qu; Weidong Gan; Zou Xiang; Xiaodong Han; Dongmei Li
Journal:  Cell Signal       Date:  2019-12-16       Impact factor: 4.315

Review 4.  The role of MDM2 and MDM4 in breast cancer development and prevention.

Authors:  Sue Haupt; Reshma Vijayakumaran; Panimaya Jeffreena Miranda; Andrew Burgess; Elgene Lim; Ygal Haupt
Journal:  J Mol Cell Biol       Date:  2017-02-01       Impact factor: 6.216

Review 5.  Metabolic recoding of epigenetics in cancer.

Authors:  Yi-Ping Wang; Qun-Ying Lei
Journal:  Cancer Commun (Lond)       Date:  2018-05-21

Review 6.  The emerging role of the piRNA/piwi complex in cancer.

Authors:  Yongmei Liu; Mei Dou; Xuxia Song; Yanhan Dong; Si Liu; Haoran Liu; Jiaping Tao; Wenjing Li; Xunhua Yin; Wenhua Xu
Journal:  Mol Cancer       Date:  2019-08-09       Impact factor: 27.401

7.  Gastric juice piR-1245: A promising prognostic biomarker for gastric cancer.

Authors:  Xiaorong Zhou; Jianhong Liu; Aifeng Meng; Lihong Zhang; Min Wang; Hong Fan; Wei Peng; Jianwei Lu
Journal:  J Clin Lab Anal       Date:  2019-11-28       Impact factor: 2.352

Review 8.  The Metabolic Mechanisms of Breast Cancer Metastasis.

Authors:  Lingling Wang; Shizhen Zhang; Xiaochen Wang
Journal:  Front Oncol       Date:  2021-01-07       Impact factor: 6.244

9.  piR-651 and its function in 95-D lung cancer cells.

Authors:  Jie Yao; Yu Wen Wang; Biao Biao Fang; Shu Jun Zhang; Bing Lin Cheng
Journal:  Biomed Rep       Date:  2016-03-08

Review 10.  Cancer epigenetics: Moving forward.

Authors:  Angela Nebbioso; Francesco Paolo Tambaro; Carmela Dell'Aversana; Lucia Altucci
Journal:  PLoS Genet       Date:  2018-06-07       Impact factor: 5.917

View more
  2 in total

Review 1.  piRNAs and PIWI proteins as potential biomarkers in ‌Breast cancer.

Authors:  Mandana AmeliMojarad; Melika Amelimojarad
Journal:  Mol Biol Rep       Date:  2022-05-25       Impact factor: 2.742

2.  Serum-derived piR-hsa-164586 of extracellular vesicles as a novel biomarker for early diagnosis of non-small cell lung cancer.

Authors:  Yanli Li; Yanhan Dong; Shupeng Zhao; Jinning Gao; Xiaodan Hao; Zibo Wang; Meng Li; Mengyuan Wang; Yiming Liu; Xiaoling Yu; Wenhua Xu
Journal:  Front Oncol       Date:  2022-09-28       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.